Works matching IS 02683369 AND DT 2009 AND VI 43

Results: 151

Adaptation of family caregivers during the acute phase of adult BMT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 959, doi. 10.1038/bmt.2008.405

By:

Fife, B. L.;
Monahan, P. O.;
Abonour, R.;
Wood, L. L.;
Stump, T. E.

Publication type:

Article

The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 941, doi. 10.1038/bmt.2008.408

By:

Hoppe, B. S.;
Moskowitz, C. H.;
Zhang, Z.;
Maragulia, J. C.;
Rice, R. D.;
Reiner, A. S.;
Hamlin, P. A.;
Zelenetz, A. D.;
Yahalom, J.

Publication type:

Article

Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 909, doi. 10.1038/bmt.2008.409

By:

Fowler, C. J.;
Dunn, A.;
Hayes-Lattin, B.;
Hansen, K.;
Hansen, L.;
Lanier, K.;
Nelson, V.;
Kovacsovics, T.;
Leis, J.;
Calandra, G.;
Maziarz, R. T.

Publication type:

Article

Pegfilgrastim for peripheral CD34+ mobilization in patients with solid tumours.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 927, doi. 10.1038/bmt.2008.411

By:

Willis, F.;
Woll, P.;
Theti, D.;
Jamali, H.;
Bacon, P.;
Baker, N.;
Pettengell, R.

Publication type:

Article

Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit?

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 919, doi. 10.1038/bmt.2008.412

By:

Merlin, E.;
Zohar, S.;
Jérôme, C.;
Veyrat-Masson, R.;
Marceau, G.;
Paillard, C.;
Auvrignon, A.;
Le Moine, P.;
Gandemer, V.;
Sapin, V.;
Halle, P.;
Boiret-Dupré, N.;
Chevret, S.;
Deméocq, F.;
Dubray, C.;
Kanold, J.

Publication type:

Article

Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 949, doi. 10.1038/bmt.2008.413

By:

Al-Hazzouri, A.;
Cao, Q.;
Burns, L. J.;
Weisdorf, D. J.;
Majhail, N. S.

Publication type:

Article

Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient.

Published in:

2009

By:

Mattei, D.;
Feola, M.;
Orzan, F.;
Mordini, N.;
Rapezzi, D.;
Gallamini, A.

Publication type:

Letter

Successful pregnancy and childbirth after reduced-intensity conditioning and partially HLA-mismatched BMT.

Published in:

2009

By:

Fuchs, E. J.;
Luznik, L.;
Bolaños-Meade, J.;
Miller, C. B.;
Brodsky, R. A.;
Ambinder, R. F.;
Jones, R. J.

Publication type:

Letter

Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 935, doi. 10.1038/bmt.2008.417

By:

Brunstein, C. G.;
Barker, J. N.;
Weisdorf, D. J.;
DeFor, T. E.;
McKenna, D.;
Chong, S. Y.;
Miller, J. S.;
McGlave, P. B.;
Wagner, J. E.

Publication type:

Article

Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 953, doi. 10.1038/bmt.2009.70

By:

Faulhaber, G. A. M.;
Premaor, M. O.;
Moser Filho, H. L.;
Silla, L. M.;
Furlanetto, T. W.

Publication type:

Article

Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 821, doi. 10.1038/bmt.2009.63

By:

Tyndall, A.;
Uccelli, A.

Publication type:

Article

Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 853, doi. 10.1038/bmt.2008.403

By:

Pourgheysari, B.;
Piper, K. P.;
McLarnon, A.;
Arrazi, J.;
Bruton, R.;
Clark, F.;
Cook, M.;
Mahendra, P.;
Craddock, C.;
Moss, P. A. H.

Publication type:

Article

The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions.

Published in:

2009

By:

Niparuck, P.;
Ungkanont, A.;
Ativitavas, T.;
Jootar, S.

Publication type:

Letter

Optimal use of G-CSF administration after hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 12, p. 895, doi. 10.1038/bmt.2009.75

By:

Trivedi, M.;
Martinez, S.;
Corringham, S.;
Medley, K.;
Ball, E. D.

Publication type:

Article

Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: alterations and differences of CLA+ T- and NK-cell fractions.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 863, doi. 10.1038/bmt.2008.392

By:

Tsuchiyama, J.;
Yoshino, T.;
Saito, T.;
Furukawa, T.;
Ito, K.;
Fuse, I.;
Aizawa, Y.

Publication type:

Article

Outcomes after auto-SCT in African Americans with multiple myeloma.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 845, doi. 10.1038/bmt.2008.401

By:

Khaled, Y.;
Abidi, M. H.;
Janakiraman, N.;
Kato, K;
Levine, J. E.;
Reddy, P.;
Medina, M;
Peres, E.;
Hanbali, A.;
Mineishi, S.

Publication type:

Article

Granzymes A and B serum levels in allo-SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 787, doi. 10.1038/bmt.2008.395

By:

Kircher, B.;
Schumacher, P.;
Nachbaur, D.

Publication type:

Article

Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 829, doi. 10.1038/bmt.2008.396

By:

Nishida, T.;
Hosaka, N.;
Takaki, T.;
Miyake, T.;
Cui, W.;
Inaba, M.;
Kinoshita, H.;
Matsuda, T.;
Ikehara, S.

Publication type:

Article

Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 875, doi. 10.1038/bmt.2008.398

By:

Feuchtinger, T.;
Pfeiffer, M.;
Pfaffle, A.;
Teltschik, H.-M.;
Wernet, D.;
Schumm, M;
Lotfi, R.;
Handgretinger, R.;
Lang, P.

Publication type:

Article

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 839, doi. 10.1038/bmt.2008.400

By:

De Padua Silva, L.;
de Lima, M.;
Kantarjian, H.;
Faderl, S.;
Kebriaei, P;
Giralt, S.;
Davisson, J.;
Garcia-Manero, G.;
Champlin, R.;
Issa, J.-P;
Ravandi, F.

Publication type:

Article

Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 779, doi. 10.1038/bmt.2008.390

By:

Novitzky, N.;
Thomas, V.;
du Toit, C.;
McDonald, A.

Publication type:

Article

Perforation of the superior vena cava after subclavian catheterization: a rare complication after autologous PBSCT.

Published in:

2009

By:

Abdelkefi, A.;
Ben Gaied, O.;
Ladeb, S.;
Labbène, I.;
Torjman, L.;
Lakhal, A.;
Ferjani, M.;
Ben Othman, T.

Publication type:

Letter

The effect of administration order of BU and CY on toxicity in hematopoietic SCT in humans.

Published in:

2009

By:

Kerbauy, F. R.;
Tirapelli, B.;
Akabane, H.;
Oliveira, J. S. R.

Publication type:

Letter

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 757, doi. 10.1038/bmt.2008.386

By:

Styczynski, J.;
Reusser, P.;
Einsele, H.;
de la Camara, R.;
Cordonnier, C.;
Ward, K. N.;
Ljungman, P.;
Engelhard, D

Publication type:

Article

Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 801, doi. 10.1038/bmt.2008.387

By:

Avivi, I.;
Avraham, S.;
Koren-Michowitz, M.;
Zuckerman, T.;
Aviv, A.;
Ofran, Y.;
Benyamini, N.;
Nagler, A.;
Rowe, J. M.;
Nagler, R. M.

Publication type:

Article

First-line thalidomide–dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 11, p. 893, doi. 10.1038/bmt.2009.113

By:

Abdelkefi, A.;
Torjman, L.;
Ben Romdhane, N.;
Ladeb, S.;
Omri, H. El;
Ben Othman, T.;
Elloumi, M.;
Bellaj, H.;
Lakhal, A.;
Jeddi, R.;
Aissaouï, L.;
Saad, A.;
Hsaïri, M.;
Boukef, K.;
Dellagi, K.;
Ben Abdeladhim, A.

Publication type:

Article

Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome.

Published in:

2009

By:

Ohwada, C.;
Nakaseko, C.;
Sakai, S.;
Takeda, Y.;
Abe, D.;
Takeuchi, M.;
Sakaida, E.;
Masuda, S.;
Shimizu, N.;
Cho, R.;
Nishimura, M.;
Kanai, K.;
Misawa, S.;
Kuwabara, S.

Publication type:

Letter

Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 793, doi. 10.1038/bmt.2008.384

By:

G. L. Uy;
Goyal, S. D.;
Fisher, N. M.;
Oza, A. Y.;
Tomasson, M. H.;
Stockerl-Goldstein, K.;
DiPersio, J. F.;
Vij, R.

Publication type:

Article

Unrelated cord blood transplantation and reduced-intensity conditioning regimen for graft failure in a child with Major Histocompatibility Complex class II deficiency.

Published in:

2009

By:

Bonduel, M.;
Staciuk, R.;
Figueroa, C.;
Oleastro, M.;
Gamba, C.;
Rossi, J.;
del Pozo, A.

Publication type:

Letter

Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 771, doi. 10.1038/bmt.2008.391

By:

Meyer-Monard, S.;
Passweg, J.;
Troeger, C.;
Eberhard, H.-P.;
Roosnek, E.;
de Faveri, G. Nicoloso;
Chalandon, Y.;
Rovo, A.;
Kindler, V.;
Irion, O.;
Holzgreve, W.;
Gratwohl, A.;
Müller, C.;
Tichelli, A.;
Tiercy, J.-M.

Publication type:

Article

Gut protection by palifermin during autologous haematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 807, doi. 10.1038/bmt.2008.388

By:

Johansson, J.-E.;
Hasséus, B.;
Johansson, P.;
Eklöf, C.;
Öhman, D.;
Stockelberg, D.

Publication type:

Article

HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 693, doi. 10.1038/bmt.2008.380

By:

Nguyen, S.;
Beziat, V.;
Dhedin, N.;
Kuentz, M.;
Vernant, J. P.;
Debre, P.;
Vieillard, V.

Publication type:

Article

Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 813, doi. 10.1038/bmt.2008.394

By:

Buyck, H. C. E.;
Ball, S.;
Junagade, P.;
Marsh, J.;
Chakrabarti, S.

Publication type:

Article

Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 685, doi. 10.1038/bmt.2008.376

By:

Saliba, R. M.;
Komanduri, K. V.;
Giralt, S.;
de Souza, J.;
Patah, P.;
Oran, B.;
Couriel, D.;
Rondon, G.;
Champlin, R. E.;
de Lima, M.

Publication type:

Article

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 717, doi. 10.1038/bmt.2008.377

By:

Schleuning, M.;
Judith, D.;
Jedlickova, Z.;
Stübig, T.;
Heshmat, M.;
Baurmann, H.;
Schwerdtfeger, R.

Publication type:

Article

A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 725, doi. 10.1038/bmt.2009.27

By:

Jarden, M.;
Baadsgaard, M. T.;
Hovgaard, D. J.;
Boesen, E.;
Adamsen, L.

Publication type:

Article

Multiple pretibial cutaneous relapses of acute myeloblastic leukemia after allogeneic BMT.

Published in:

2009

By:

Juárez, Á;
Goiriz, R;
Domínguez-Fernández, I;
Gómez-García de Soria, V;
Cámara, R;
Fraga, J;
García-Diez, A

Publication type:

Letter

Interactive diagnostics in the indication to allogeneic SCT in AML.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 10, p. 745, doi. 10.1038/bmt.2009.54

By:

Bacher, U.;
Haferlach, C.;
Schnittger, S.;
Kern, W.;
Kroeger, N.;
Zander, A. R.;
Haferlach, T.

Publication type:

Article

Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 709, doi. 10.1038/bmt.2008.375

By:

Malladi, R. K.;
Peniket, A. J.;
Littlewood, T. J.;
Towlson, K. E.;
Pearce, R.;
Yin, J.;
Cavenagh, J. D.;
Craddock, C.;
Orchard, K. H.;
Olavarria, E.;
McQuaker, G.;
Collin, M.;
Marks, D. I.

Publication type:

Article

Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantation.

Published in:

2009

By:

Dulley, F. L.;
Costa, S.;
Cosentino, R.;
Gamba, C.;
Saboya, R.

Publication type:

Letter

Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 679, doi. 10.1038/bmt.2008.385

By:

Masjosthusmann, K.;
Ehlert, K.;
Eing, B. R.;
Roth, J.;
Koehler, G.;
Juergens, H.;
Fruehwald, M;
Groll, A. H.

Publication type:

Article

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 669, doi. 10.1038/bmt.2009.59

By:

Kobbe, G.;
Bruns, I.;
Fenk, R.;
Czibere, A.;
Haas, R.

Publication type:

Article

Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 9, p. 701, doi. 10.1038/bmt.2008.382

By:

Hicks, L. K.;
Woods, A.;
Buckstein, R.;
Mangel, J.;
Pennell, N.;
Zhang, L.;
Imrie, K.;
Spaner, D.;
Cheung, M. C.;
Boudreau, A.;
Reis, M.;
Crump, M.;
Berinstein, N. L.

Publication type:

Article

Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?

Published in:

2009

By:

Gale, R P;
Eapen, M;
Logan, B;
Zhang, M-J;
Lazarus, H M

Publication type:

Correction Notice

Outcome of allo-SCT for chronic myelomonocytic leukemia.

Published in:

2009

By:

Ocheni, S.;
Kröger, N.;
Zabelina, T.;
Zander, A. .R;
Bacher, U.

Publication type:

Letter

Outcomes of transplantation of unrelated cord blood in children with malignant and non-malignant diseases: an Utrecht–Prague collaborative study.

Published in:

2009

By:

Boelens, J. J.;
Bierings, M.;
Tilanus, M.;
Lie, J.;
Sedlacek, P.

Publication type:

Letter

Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 8, p. 627, doi. 10.1038/bmt.2008.368

By:

Boxall, S. A.;
Cook, G. P.;
Pearce, D.;
Bonnet, D.;
El-Sherbiny, Y. M.;
Blundell, M. P.;
Howe, S. J.;
Leek, J. P.;
Markham, A. F.;
de Wynter, E. A.

Publication type:

Article

Prophylaxis regimens for GVHD: systematic review and meta-analysis.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 8, p. 643, doi. 10.1038/bmt.2008.373

By:

Ram, R.;
Gafter-Gvili, A.;
Yeshurun, M.;
Paul, M.;
Raanani, P.;
Shpilberg, O.

Publication type:

Article

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.

Published in:

Bone Marrow Transplantation, 2009, v. 43, n. 8, p. 619, doi. 10.1038/bmt.2008.369

By:

Gertz, M. A.;
Kumar, S. K.;
Lacy, M. Q.;
Dispenzieri, A.;
Hayman, S. R.;
Buadi, F. K.;
Dingli, D.;
Gastineau, D. A.;
Winters, J. L.;
Litzow, M. R.

Publication type:

Article

Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions.

Published in:

2009

By:

Alegre, A.

Publication type:

Editorial